Which factors influence psychiatrists' selection of antidepressants?

被引:114
作者
Zimmerman, M [1 ]
Posternak, M [1 ]
Friedman, M [1 ]
Attiullah, N [1 ]
Baymiller, S [1 ]
Boland, R [1 ]
Berlowitz, S [1 ]
Rahman, S [1 ]
Uy, K [1 ]
Singer, S [1 ]
机构
[1] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA
关键词
D O I
10.1176/appi.ajp.161.7.1285
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: There is little empirical evidence to guide clinicians in choosing among the diverse array of antidepressants available. In the absence of replicated empirical research guiding the selection of antidepressants, it is of interest to examine what factors psychiatrists consider when prescribing antidepressants. Method: For 1,137 depressed patients who received a new antidepressant prescription, the treating psychiatrist completed a 43-item questionnaire listing factors that might have influenced the choice of antidepressant medication. The questionnaire was filled out immediately after an antidepressant was prescribed to treat a depressive disorder. Results: The most common factors influencing antidepressant selection were the avoidance of specific side effects, the presence of comorbid psychiatric disorders, and the presence of specific clinical symptoms. Prior treatment history, including prior positive or failed response to a drug, was the next most frequently endorsed factor influencing medication choice. Some factors that have been commonly discussed in the literature, such as concern about discontinuation syndrome and drug-drug interactions, rarely influenced antidepressant selection. Conclusions: Because relatively little research has examined clinical features associated with differential response to the newer generation of antidepressants, a study of psychiatrists' prescribing practices highlights priorities for future controlled research. Our results suggest that two priority areas are the treatment of depression with coexisting anxiety symptoms/anxiety disorders and the influence of particular symptoms on response to different medications.
引用
收藏
页码:1285 / 1289
页数:5
相关论文
共 19 条
[1]  
[Anonymous], 2017, TREATM GUID 2 MAJ DE
[2]   Psychomotor changes in melancholic and atypical depression: unipolar and bipolar-II subtypes [J].
Benazzi, F .
PSYCHIATRY RESEARCH, 2002, 112 (03) :211-220
[3]  
Fawcett J, 1997, J CLIN PSYCHIAT, V58, P35
[4]  
Krishnan KRR, 2002, J CLIN PSYCHIAT, V63, P25
[5]   Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study [J].
Melartin, TK ;
Rytsälä, HJ ;
Leskelä, US ;
Lestelä-Mielonen, PS ;
Sokero, TP ;
Isometsä, ET .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (02) :126-134
[6]  
Nemeroff Charles B, 2002, Psychopharmacol Bull, V36 Suppl 2, P6
[7]   Substance-P antagonists: a new treatment for depression? [J].
Nutt, D .
LANCET, 1998, 352 (9141) :1644-1646
[8]   Antidepressant prescribing practices of outpatient psychiatrists [J].
Olfson, M ;
Marcus, SC ;
Pincus, HA ;
Zito, JM ;
Thompson, JW ;
Zarin, DA .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (04) :310-316
[9]   National trends in the outpatient treatment of depression [J].
Olfson, M ;
Marcus, SC ;
Druss, B ;
Elinson, L ;
Tanielian, T ;
Pincus, HA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (02) :203-209
[10]   A survey of prescribing practices in the treatment of depression [J].
Petersen, T ;
Dording, C ;
Neault, NB ;
Kornbluh, R ;
Alpert, JE ;
Nierenberg, AA ;
Rosenbaum, JF ;
Fava, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (01) :177-187